Physician
NG, Karen
NG, Karen was paid $890K by Medicaid between Jan 2018 and Dec 2024, across 42 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 41% of everything it billed.
33Billing provider infoNG, KAREN
PROVIDENCE, RI 02909
PROVIDENCE, RI 02909
33aNPI1508859109assigned 08/30/2005
33bProvider typeFamily Medicine Physician
28Total paid$890K
24GClaims23,529
24DCodes billed42
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Rhode Island
Rank by total paid#9 of 220
Median peer was paid$33K
This provider vs. median27×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,107 | $169K | |
| 2019 | 322 | $9K | |
| 2020 | 2,977 | $117K | |
| 2021 | 4,510 | $151K | |
| 2022 | 3,940 | $142K | |
| 2023 | 3,780 | $169K | |
| 2024incomplete | 2,893 | $132K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 41% | 6,670 | 6,042 | $362K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 2,388 | 2,270 | $159K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.1% | 833 | 821 | $63K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.3% | 544 | 528 | $47K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.1% | 645 | 545 | $37K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.3% | 400 | 386 | $29K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3.1% | 3,266 | 3,170 | $28K |
| 87428 | 2.9% | 452 | 439 | $26K | |
| 99051 | 2.3% | 866 | 840 | $20K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.2% | 630 | 586 | $20K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 2.1% | 1,185 | 1,149 | $18K |
| G0467 | Community health center visit, returning patientFederally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 1.3% | 66 | 53 | $12K |
30 more codes
| 99238 | Hospital discharge day management, 30 minutes or less | 1.1% | 181 | $10K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.0% | 1,446 | $9K |
| 99460 | <1% | 148 | $7K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 417 | $6K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 92 | $6K |
| 0012A | <1% | 120 | $5K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 472 | $4K |
| 90461 | <1% | 129 | $4K | |
| 0011A | <1% | 126 | $3K | |
| 82962 | <1% | 1,398 | $2K | |
| 0124A | <1% | 48 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 154 | $2K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 49 | $1K |
| 90480 | <1% | 40 | $1K | |
| 0071A | <1% | 27 | $1K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 65 | $832.56 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 12 | $802.29 |
| 0054A | <1% | 22 | $755.65 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 36 | $725.30 |
| 0072A | <1% | 18 | $709.65 | |
| 99442 | <1% | 24 | $695.28 | |
| 92587 | <1% | 13 | $631.68 | |
| 0134A | <1% | 13 | $501.04 | |
| 0064A | <1% | 22 | $450.39 | |
| 94760 | <1% | 186 | $408.63 | |
| 99462 | <1% | 16 | $394.56 | |
| 96127 | <1% | 62 | $154.42 | |
| 90686 | <1% | 221 | $53.62 | |
| 96160 | <1% | 14 | $45.08 | |
| 81002 | <1% | 13 | $27.60 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.